Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Newton, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Acer Therapeutics Inc. has filed 1,254 SEC EDGAR filings since 08 Mar 1999

SEC filing history

Showing 501-525 of 785 matching filings.

Per page
25
Current page
21
8-K File 001-33004

FORM 8-K

Filing date
09 Apr 2015
Reporting date
09 Apr 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-A12B File 001-33004

8-A12B

Filing date
08 Apr 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
01 Apr 2015
Reporting date
30 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
01 Apr 2015
Reporting date
30 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
01 Apr 2015
Reporting date
30 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
01 Apr 2015
Reporting date
30 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
01 Apr 2015
Reporting date
30 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33004

FORM 8-K

Filing date
01 Apr 2015
Reporting date
31 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-201731

424B3

Filing date
01 Apr 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-201731

OPEXA THERAPEUTICS, INC. 424B3

Filing date
09 Mar 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33004

OPEXA THERAPEUTICS, INC. 8-K

Filing date
09 Mar 2015
Reporting date
09 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Mar 2015
Reporting date
02 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Mar 2015
Reporting date
02 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Mar 2015
Reporting date
02 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-201731

EFFECT filing

Filing date
25 Feb 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33004

FORM 8-K

Filing date
25 Feb 2015
Reporting date
25 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-201731

424B4

Filing date
25 Feb 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-201731

S-1/A

Filing date
24 Feb 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-201731

S-1/A

Filing date
24 Feb 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33004

OPEXA THERAPEUTICS, INC.

Filing date
23 Feb 2015
Reporting date
23 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-33004

OPEXA THERAPEUTICS, INC. 10-K

Filing date
23 Feb 2015
Reporting date
31 Dec 2014
Next action
Verify source filing
FWP File 333-201731

FWP

Filing date
28 Jan 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33004

FORM 8-K

Filing date
28 Jan 2015
Reporting date
28 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1 File 333-201731

FORM S-1

Filing date
28 Jan 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33004

OPEXA THERAPEUTICS, INC. 8-K

Filing date
09 Dec 2014
Reporting date
05 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .